154 results on '"Gerotto, M"'
Search Results
2. Utilização de caulim e meta-caulim em substituição à microssílica em concretos refratários aluminosos auto-escoantes
3. Evolution of Hepatitis C Virus Quasispecies in Children with Chronic Hepatitis C
4. Detailed analysis of the E2–IgM complex in hepatitis C-related type II mixed cryoglobulinaemia
5. Hepatitis C virus quasispecies in the natural course of HCV-related disease in patients with haemophilia
6. Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-α
7. EVIDENCE FOR REDUCED RATES OF QUASISPECIES DIVERSIFICATION DURING COMBINATION INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C
8. MERCURY, SELENIUM AND ARSENIC DETERMINATION IN SEAWATER AND MARINE ORGANISMS BY ZEEMAN GFAAS
9. DETERMINATION OF MERCURY AND SELENIUM IN BIOLOGICAL SPECIMENS BY ZEEMAN GFAAS
10. WP3/17 TRANSLATIONAL ACTIVITY OF THE 5'UTR OF HCV: DIFFERENCES BETWEEN GENOTYPES, NATURALLY OCCURRING VARIANTS AND ARTIFICIAL MUTANTS
11. Hepatitis C Virus Genotypes HCV-1a and HCV-1b: The Clinical Point of View
12. Microsomal triglyceride transfer protein polymorphism (-493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C
13. Insulin resistance (IR) defined by the homeostasis model of assessment insulin resistance (HOMA-IR) index has a direct effect on early viral kinetics during pegylated-interferon therapy for chronic hepatitis C
14. Variability in the CK2 dependent phosphorylation of NS5A among HCV genotypes: Possible implications in caspases cleavage
15. Microsomal triglyceride transfer protein (MTP) gene polymorphism and lipid metabolism in HCV-infected patients
16. A cirrhosis risk score identifies those chronic hepatitis C infected patients presenting with no liver fibrosis that are at high risk for fibrosis progression
17. Liver microsomal triglyceride transfer protein is involved in hepatitis C related liver steatosis
18. Liver microsomal trygliceride transfer protein (MTP) is involved in HCV related hepatic steatosis through genotype specific pathways
19. Highly homogeneous E2-HCV associated with the expansion of specific B cell monoclones in patients with mixed cryoglobulinemia
20. PKR gene expression and response to pegylated interferon plus ribarin therapy in chronic hepatitis C
21. Utilização de caulim e meta-caulim em substituição à microssílica em concretos refratários aluminosos auto-escoantes
22. SEQUENCE ANALYSIS OF TWO PKR INHIBITOR HCV PROTEINS: CORRELATION WITH EARLY AND SUSTAINED RESPONSE TO INTERFERON THERAPY
23. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C
24. LA DIAGNOSI DI LABORATORIO NELL'EPATITE
25. THE EFFECT OF RE-TREATMENT WITH INTERFERON ALONE OR INTERFERN PLUS RIBAVIRIN ON HCV QUASISPECIES DIVERSIFICATION IN NONRESPONDER PATIENTS WITH CHRONIC HEPATITIS C
26. DIFFERENT RATES OF HCV QUASISPECIES DIVERSIFICATION IN ASYMPTOMATIC CARRIERS AND IN PATIENTS WITH CHRONIC HEPATITIS
27. Coinfection by hepatitis B virus and hepatitis C virus
28. Endogenous interferon-alpha concentration and outcome of interferon treatment in patients with chronic hepatitis C
29. LA BIOLOGIA MOLECOLARE NELLA DIAGNOSTICA DELLE EPATITI VIRALI
30. TRANSLATIONAL ACTIVITY OF THE 5’UTR OF HCV : DIFFERENCES BETWEEN GENOTYPES, NATURALLY OCCURRING VARIANTS AND ARTIFICIAL MUTANTS
31. DIFFERENT EFFICIENCY OF INITIATION OF TRANSLATION BY 5’UTR OF HEPATITIS C VIRUS TYPES AND OF NATURALLY OCCURRING VARIANTS
32. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection
33. HCV-RNA SEQUENCES IN SERUM AND IN PBMC IN VIREMIC PATIENTS WITH BIOCHEMICAL SUSTAINED RESPONSE TO INTERFERON : RELATION TO PRE-TREATMENT SEQUENCES
34. GENOMIC INTERFERON SEQUENCES AND APPEARANCE OF ANTI-IFN DURING INTERFERON THERAPY
35. DISTRIBUITON OF THREE MAJOR HCV GENOTYPES IN ITALY. A MULTICENTRIC STUDY OF 495 PATIENTS WITH CHRONIC HEPATITIS C
36. CHARACTERIZATION OF HCV-RNA SEQEUNCES IN PATIENTS WITH PERSISTENT VEIREMIA AFTER BIOCHEMICAL RESPONSE TO INTERFERON
37. HCV GENOTYPES AND INTRAFAMILIAL SPREADING OF HCV INFECTION
38. TRANSLATIONAL EFFICIENCY OF DIFFERENT GENOTYPES OF HCV AND OF NATURALLY OCCURRING MUTANTS
39. INTRAFAMILIAL SPREADING OF HCV INFECTION: ANALYSIS OF HCV GENOTYPES
40. GENOMIC CHARACTERIZATION OF HCV IN VIREMIC PATIENTS WITH NORMAL ALT
41. HCV-1a VS HCV-1b : THE CLINICAL POINT OF VIEW
42. HCV GENOTYPES IN PATIENTS WITH CHRONIC HEPATITIS C AND SILENT HCV INFECTION AFTER SUSTAINED BIOCHEMICAL RESOPNSE TO INTERFERON
43. ANALYSIS OF THE HEPATITIS C VIRUS GENOME IN PATIENTS WITH ANTI-LKM-1 AUTOANTIBODIES
44. A MULTICENTRIC STUDY ON DISTRIBUTION AND CLINICAL FEATURES OF HCV GENOTYPES IN CHRONIC HEPATITIS C IN ITALY
45. HCV GENOTYPES AND RESPONSE TO INTERFERON IN ITALIAN PATIENTS
46. COMPARISON OF THREE METHODS FOR THE GENOTYPING OF HCV
47. CLINICAL FEATURES AND RESPONSE TO INTERFERON IN PATIENTS WITH DIFFERENT HCV GENOTYPES IN ITALY
48. COMPARISON OF HCV GENOTYPES VS SEROTYPING IN CHRONIC HEPATITIS C
49. GENOTYPE DISTRIBUTION IN PATIENTS WITH CHRONIC HEPATITIS C IN ITALY
50. DOT- BLOT ASSAY WITH 5'UTR GENOTYPE-SPECIFIC OLIGONUCLEOTIDE PROBES ALLOWS IDENTIFICATION OF DISTINCT GENOTYPES OF HCV
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.